Michael Hinds

740 citations
18 papers · 641 · h-index 10

Impact in

Papers in

Michael Hinds

18 papers receiving 616 citations

Peers

Michael Hinds
Comparison fields: 5 of 60
  • Toxicology 84
  • Molecular Medicine 57
  • Oncology 267
  • Molecular Biology 526
  • Genetics 91
Replace Michael F. Belcourt with:
Michael F. Belcourt United States
U. Schomburg Germany
Anna Valenti Italy
Anne-Marie de Recondo France
Anikó Hevér Hungary
Yasunori Funayama Japan
Kay Osborn United Kingdom
Yingqing Mao China
Hisaji Yamazaki Japan
Cintia Cruz Argentina
Michael Hinds relative to Michael F. Belcourt United States Michael F. Belcourt's profile →
Citations per field
00.5×4.1×
Michael F. Belcourt · 1×
Citations per year

Countries citing papers authored by Michael Hinds

Since Specialization
Citations

This map shows the geographic impact of Michael Hinds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hinds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hinds more than expected).

Fields of papers citing papers by Michael Hinds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hinds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hinds. The network helps show where Michael Hinds may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Hinds, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Hinds Line = papers co-authored together Michael Hinds links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 1989159
2
Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.
1991126
3 198253
4 199048
5 198244
6 199137
7 198237
8
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
199033
9
Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
198832
10
Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.
199222
11 19919
12 19908
13 19938
14 19888
15 19928
16 19944
17 19914
18 19911

About Michael Hinds

Michael Hinds is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Oncology, Genetics and Plant Science, having authored 18 papers that have together received 641 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), Acute Lymphoblastic Leukemia research (7 papers), Lung Cancer Research Studies (4 papers), Bacterial Genetics and Biotechnology (3 papers), DNA Repair Mechanisms (3 papers), DNA and Nucleic Acid Chemistry (3 papers), Legume Nitrogen Fixing Symbiosis (3 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Toxicology (84 citations), Molecular Medicine (57 citations), Oncology (267 citations), Molecular Biology (526 citations) and Genetics (91 citations). Michael Hinds has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Janice Mayes, R J Meyer, Leonard A. Zwelling, Diana Chan, Elizabeth Altschuler, Lynn Silberman, Karl Deisseroth, Mark Blick, Fred D. Ledley and Michael A. Brasch. Their work appears in journals such as Biochemical Pharmacology, Journal of Bacteriology, JNCI Journal of the National Cancer Institute, Journal of Biological Chemistry and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact